“The Matrix” was always an allegory for awakening to your full potential, and the fourth sequel creates the proper set and setting to dive even further through the looking glass. The world let out a collective gasp in 1999 when a hacker named Neo (Keanu Reeves) discovered he’d been living inside a digital simulation designed…
Did Canada just legalize Psychedelic therapy? Psychedelic therapies, such as psilocybin therapy for depression and MDMA therapy for PTSD, could soon be legal in Canada, at least for some patients. Over the holidays, Health Canada, a regulatory body similar to the FDA made a change to something called their Special Access Program (SAP). This program,…
MindMed’s Project Lucy is Delayed and Compass Pathways Has a Patent Being Challenged. In today’s episode, we discuss two companies: MindMed (NASDAQ: MNMD, NEO: MMED); and Compass Pathways (NASDAQ: CMPS). For MindMed, unfortunately, their flagship program, Project Lucy, has been delayed. Project Lucy is attempting to treat Generalized Anxiety Disorder using LSD therapy. MindMed had…
Spider-Man’s Secret War: How the Web Crawler and Stan Lee Fought the War on Drugs Follow us on Twitter: @PsycSpotlight @Psy_Invest @psy_holy Follow us on Instagram: @psycspotlight @thepsychedelicinvestor To learn more about the emerging psychedelic industry, visit: Psychedelic Spotlight Welcome back to another episode. As Spider-Man: No Way Home swings into theaters, every teenager and…
In today’s episode of the Psychedelic Spotlight podcast, the Psychedelic Investor, James Hallifax interviews Ian McDonald, CEO and Director of Bright Minds Biosciences. For any investors out there, you can find Bright Minds Biosciences trading on the Canadian Securities Exchange under the symbol $DRUG and on the American OTC market under the symbol $BMBIF. In…
David Flores, CEO of Global Trac Solutions (PSYC), joins Cheddar to discuss the company’s digital media platform ‘Psychedelic Spotlight’, factors contributing to a more open-minded approach to psychedelics among the scientific and medical communities, and why investors are seeing the psychedelic market as an opportunity for growth. #business #psychedelics #investments source
In this episode of the Psychedelic Spotlight podcast, we connect with Douglas K. Gordon, CEO of Silo Wellness, a wellness company in the psychedelics and functional mushroom marketplace. In our conversation with Douglas, we discuss the company’s collaboration with the Bob Marley Estate, and their recent expansion to the Frankfurt Exchange. *To learn more about…
In this episode of the Psychedelic Spotlight podcast, we speak with Rabbi Zac Kamenetz, the Founder, and CEO of Shefa and the Co-Founder of the Jewish Psychedelic Summit. In our conversation with Rabbi Zac, we discussed the forthcoming Jewish Psychedelic Summit, which kicks off on May 2, 2021, and which, in addition to himself, is…
In this episode of the Psychedelic Spotlight podcast, we speak with Joshua White, the Co-Founder and Director of Fireside Project, the first Psychedelic Peer Support Line. Joshua speaks about the creation of the Fireside Project and the future of the organization. *To learn more about the company featured in this episode and the work they’re…
In this episode of the Psychedelic Spotlight podcast, we speak with Pierre Bouchard, a psychotherapist from Boulder, CO. Pierre talks about the delivery of ketamine therapy and what patients can expect going into a session. *Get the latest industry news around all things psychedelics by visiting our website, and be sure to subscribe to our…
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.